Navigation Links
Sagent Pharmaceuticals Enters Into a $15 Million Revolving Credit Facility
Date:6/19/2009

SCHAUMBURG, Ill., June 19 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced today that it has entered into a $15 million revolving credit facility with MidCap Financial LLC. Proceeds from the new facility will be used to support increasing working capital requirements and for general corporate purposes.

"Following closely on our recent $30 million Series A extension, this facility provides Sagent with non-dilutive capital and additional liquidity to support the company's significant upcoming product introductions and accelerated growth," said Ronald E. Pauli, Sagent's chief financial officer. "With a focus on middle-market lending in the healthcare space, MidCap Financial was ideally situated to provide an innovative deal structure tailored to Sagent's needs. We look forward to a long and productive partnership with MidCap."

About Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals, founded in 2006, is a privately held specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients. Sagent currently has more than 200 products in development.

To Discover Injectables Excellence(TM) and learn more about Sagent, please visit www.SagentPharma.com.

About MidCap Financial LLC

MidCap Financial is a commercial finance company focused on middle market lending in healthcare and other specialty vertical markets. MidCap specializes in middle market loans in the $10 million to $200 million range. Its principal officers are all veterans of the healthcare finance industry, having worked together at three healthcare finance companies previously. The company is headquartered in Bethesda, MD, with offices in Chicago and Los Angeles. Additional information about MidCap Financial can be found at www.midcapfinancial.com.


'/>"/>
SOURCE Sagent Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sagent Pharmaceuticals Inc. Completes $53 Million Series A Financing
2. Sagent Pharmaceuticals Launches Ciprofloxacin Injection, USP, 5% Dextrose Premix Bag
3. Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP
4. Sagent Pharmaceuticals Announces Presentations at Upcoming Lazard Capital Markets and Piper Jaffray Healthcare Conferences
5. Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
6. Sagent Pharmaceuticals Announces Extension of Series A Financing
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... ... The Case Management Society of America (CMSA) will install six new members ... has elected their upcoming President-Elect, Secretary, Treasurer and two Directors to serve on the ... position has also been added to the BOD, per an appointment made by CMSA ...
(Date:3/27/2017)... ... 2017 , ... EpiGentek , a Farmingdale, NY-based biotech ... methylation “gold rush” with their established portfolio of optimized assay kits that measure ... m6A , RNA methylation has received a new burst in interest as ...
(Date:3/27/2017)... Ranch, California (PRWEB) , ... March 27, 2017 , ... ... commitment to its customers. First National Capital has added 10 new sales professionals over ... grow its sales positions by 15 additional new hires over the course of 2017. ...
(Date:3/27/2017)... ... March 27, 2017 , ... From ... opioids alone responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) ... (AB) 1512, which proposes a tax on prescription opioids to fund drug rehabilitation ...
(Date:3/25/2017)... (PRWEB) , ... March 25, 2017 , ... Norland at Swissray is pleased ... analyzers for large subjects. The ELITE DXA has an active scan window, which is ... or long to fit in the scan area could not undergo an accurate total body ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  BERG, ... a data-driven, biological research approach, today announced ... to the discovery of new data using ... facilitate brown fat metabolism. Joslin Diabetes Center ... Interrogative Biology® platform for analysis of samples.  ...
(Date:3/27/2017)... -- Twist Bioscience, a company accelerating science and innovation through ... an additional $33 million. To date, Twist Bioscience has ... "It is an exciting time to be leading Twist ... deliver industry-leading gene volume to our customers, enabling innovative ... Ph.D., CEO of Twist Bioscience. "We welcome the additional ...
(Date:3/27/2017)... March 27, 2017 Arena Pharmaceuticals, Inc. ... developing novel, small molecule drugs across multiple therapeutic areas, today ... Executive Officer, will present a corporate update at the 16th ... ET.  The conference will take place April 4-5, 2017 at ... York , NY.  A live audio ...
Breaking Medicine Technology: